Research

Marine Phytoplankton: Let the Nutrition Out

A condensed guide to the published studies on two cultivated marine microalgae, with every reference listed.

The original Marine Phytoplankton article illustration

The organism

This strain of phytoplankton came into my world after seeing the story of Tom Harper, a man who was cultivating phytoplankton for shellfish farming. When he got cancer he intuitively started scooping phytoplankton out of the cultivation vats and something rather magic happened. This started a decades long refinement of the cultivation process this time for human consumption.

This page covers one organism in particular. That organism is Microchloropsis gaditana, a single-celled alga that drifts in the sea and is also cultivated in tanks originally for shellfish cultivation before its discovery as a potent nutritional food for human consumption. I will call it gaditana from here on (a name I will untangle shortly). I am not a neutral reviewer of these algae. I have taken them for about ten years, and my cat has eaten them for years and is thriving. None of that is a clinical trial, and I will not dress it up as one.

The second ingredient in one of the two products is a different alga, Tetraselmis chuii. It is a second well-studied organism with its own record, and it gets its own section near the end, kept separate so no result is ever blurred.

What the cell is

Gaditana belongs to the eustigmatophytes, a less familiar group of single-celled algae. Until 2015 it was Nannochloropsis gaditana, a name L. M. Lubián gave it in 1982 (1). This is the name I always knew it by. In 2015 Fawley, Jameson and Fawley moved it into a new genus, Microchloropsis (2).

Why running out of nitrogen turns the cell into an oil tank

Two side-by-side cells: fed with nitrogen versus nitrogen starved, showing the lipid switch.
The panel figures are the genus picture: a Nannochloropsis strain at about thirty-two percent lipid when well fed and about sixty percent after nitrogen starvation (Rodolfi 2009). The gaditana-specific figure is thirty-eight percent of dry weight as storage fat (Simionato 2013). Both are strain- and culture-dependent.

Fed plenty of nitrogen, the nutrient it needs to build protein, this cell grows and divides. Take the nitrogen away and it stops dividing and packs away fat, which makes it oleaginous, meaning oil-storing. A Nannochloropsis strain studied by Rodolfi and colleagues in 2009 held about thirty-two percent lipid (fat, in plain words) by dry weight when well fed and reached sixty percent after nitrogen starvation (3). The gaditana-specific work came from Simionato and colleagues in 2013 (4).

They starved Nannochloropsis gaditana of nitrogen and watched it build triacylglycerol from scratch (the storage form of fat, the same family of molecule that sits in your own fat cells). About thirty-eight percent of the dry weight ended up as that storage fat.

An EPA-rich omega-3 profile and a pigment fingerprint

The composition fingerprint: EPA present, DHA absent, violaxanthin, chlorophyll a only.
The documented fingerprint: EPA present, DHA absent, violaxanthin as the signature carotenoid, and chlorophyll a only.

The stored fat leans toward EPA (eicosapentaenoic acid, the omega-3 fat people associate with fish oil), and a 2025 review by Navalho and colleagues describes the genus as accumulating polyunsaturated fats, especially EPA (5). The oil in the one human trial carried more than twenty-five percent EPA among its fatty acids and no DHA, according to Rao and colleagues in 2020 (6). DHA (docosahexaenoic acid, EPA's usual partner in fish oil) is missing, so this is a real difference from fish oil.

The body builds DHA from the shorter omega-3 fats in green plants and seeds. Alpha-linolenic acid goes to EPA, and EPA goes on to DHA, and your body runs that conversion itself (7). EPA also has its own record. Icosapent ethyl is a prescription form of EPA at gram doses, and in the REDUCE-IT trial it cut heart attacks, strokes and cardiovascular death in people already on statins (8). The mixed EPA and DHA fish oil formulas largely failed to repeat that.

So EPA on its own is not the lesser half of fish oil. It is the half the outcome evidence actually landed on. This alga makes chlorophyll a and no other chlorophyll, which is typical of its group. Its signature yellow-orange pigment is violaxanthin, a xanthophyll (one of the carotenoids, the family that colors carrots and egg yolks). Lima and colleagues in 2021 grew Nannochloropsis gaditana under flashing LED light and found beta-carotene and violaxanthin (9).

Culetu and colleagues in 2026 compared five microalgae and picked out violaxanthin as the signature of Nannochloropsis oculata, a relative (10). One pigment does not belong on that list, and that is fucoxanthin. It is the golden-brown pigment of diatoms and brown seaweeds, and Culetu's comparison found it in the diatom Phaeodactylum tricornutum (10). Composition is where a label usually goes quiet, so here are real numbers. Nacer and colleagues analyzed gaditana biomass in 2020 and reported about 28 grams of protein, 18.4 grams of fat and 45 grams of carbohydrate per 100 grams of dry matter (11).

The wall between the powder and the gut

The cell wall of gaditana is real, and it is a serious piece of engineering. Scholz and colleagues took apart the wall of the reference strain in 2014 and found two layers (12). The inner wall is cellulose (the tough fiber that stiffens plant stems) and makes up roughly three quarters of the wall's mass. Over it sits algaenan, a waxy polymer with cross-linked chains. That structure is tough enough that the authors describe it as a barrier to extracting oil from the cell industrially, which is a statement about processing, not about digestion.

The closest measurements come from its close relative Nannochloropsis oculata, and they point one way. Cavonius and colleagues ran intact cells through a standard laboratory digestion model in 2016 and reported that neither the protein nor the lipid inside them was reachable by the digestive enzymes they used (13). Wild and colleagues, measuring sixteen commercial microalgae products in 2018, got a crude protein digestibility of about 54 percent for non-disrupted Nannochloropsis against 84 percent for cell-disrupted Chlorella (14).

The freeze-drying step is what opens the cell. It leaves microfractures across the cell wall, so the nutrients inside are reachable without a separate breaking step, and that is the mechanism by which the powder is absorbed.

How a culture becomes a powder

None of this is wild harvest. Rodolfi's group grew their strain in closed flat-panel photobioreactors (transparent tanks that let sunlight in and keep contamination out), twenty liters indoors and 110 liters outdoors (3). They projected more than ninety kilograms of oil per hectare per day (a hectare is about two and a half acres) in a two-phase process: grow fast with plenty of nitrogen, then starve the culture so the cells load up with oil.

Navalho and colleagues write that the genus is "mainly marketed as a feed ingredient in aquaculture" (5), so the human supplement is a side street off the main road but it has been refined in the last decade and is now cultivated in a pristine facility in Spain for human consumption.

What fish, sheep and cells in dishes have shown

Most of the real evidence on this alga comes from animals. Ferreira and colleagues in 2009 enriched rotifers (tiny animals that serve as the first live food for fish larvae) with Nannochloropsis gaditana, and the rotifers roughly doubled their dry weight, protein, fat and carbohydrate and carried more EPA up the food chain (15). Díaz and colleagues in 2025 fed Atlantic salmon spray-dried Microchloropsis gaditana for forty-nine days (16). Fillet EPA plus DPA (a second omega-3 fat) rose twenty-three percent, fillet vitamin D3 rose 106 percent, and serum activity against Piscirickettsia salmonis, a bacterial pathogen of farmed salmon, rose about eighty-six percent.

Mavrommatis and colleagues in 2026 fed lactating ewes the marine microorganism Schizochytrium, alone or with Nannochloropsis gaditana, and the milk carried more EPA without losing yield (17). In cells rather than animals, González-Arceo and colleagues in 2025 treated mouse fat-cell precursors (a standard lab line called 3T3-L1) with a protein-rich extract of Microchloropsis gaditana (18). Maturing cells stored less triglyceride and their development into fat cells was suppressed, though mature fat cells did not respond. It is a dish result, and I draw no conclusion for a person from it.

More from rats, and more cells in dishes

Bar comparison of diabetic rats fed gaditana against untreated diabetic rats, with healthy control values shown.
Nacer 2020: two months on a diet that was one tenth gaditana moved blood glucose, HbA1c, blood fats and liver antioxidant enzymes in the right direction, while the treated rats stayed well short of the healthy controls (11).

The strongest extra gaditana evidence is a rat study. Nacer and colleagues made male Wistar rats diabetic with streptozotocin (a drug that destroys insulin-producing cells) and fed them a diet that was 10 percent gaditana for two months (11). Against untreated diabetic rats, the gaditana-fed rats had blood glucose of 2.44 grams per liter instead of 4.41, HbA1c (glycated hemoglobin, a measure of average blood sugar) of 9.6 percent instead of 10.7, triglycerides of 1.94 instead of 2.28 grams per liter, and cholesterol of 2.02 instead of 2.43.

TNF-α and IL-6 (inflammatory signaling proteins) were significantly lower. In liver tissue, MDA (a breakdown product of oxidized fat) fell from 3.30 to 2.15 micromoles per gram, while catalase rose from 46.53 to 57.26 units per gram, superoxide dismutase from 1.61 to 2.37 and glutathione from 2.56 to 3.56. The treated rats were still far from healthy: glucose of 2.44 against 1.17 in healthy controls, and HbA1c of 9.6 percent against 4.4 (11).

This is one rat study, one strain grown in several closed photobioreactors at one site, no human data. A diet that is a tenth algae is not a scoop, and I draw no conclusion about diabetes in a person from it but would say considering how damaging streptozotocin is to these rats any improvement in these markers is still impressive. Martínez and colleagues in 2022 fed rats a diet that was 20 percent gaditana and also tested extracts from biomass with treated or untreated cell walls (19). Liver antioxidant activity rose, and hepatic fat content fell significantly while the change in plasma triglycerides did not reach significance; the extracts also slowed cancer cell growth in a dish.

Five more papers are cell studies only, reported as laboratory findings and nothing more. Three used cancer cell lines. Carrasco-Reinado and colleagues in 2021 found a gaditana compound that slowed Caco-2 colon and HepG2 liver cancer cells (20). Ávila-Román and colleagues in 2016 found that 15-HEPE, an oxylipin (an oxidized fat molecule) from gaditana, was toxic to UACC-62 melanoma and HT-29 colon cells (21). That was one isolated molecule, not whole algae.

Additionally Castejón and Marko in 2022 found a lipid extract toxic to HCT-116 colon cancer cells while sparing nontumorigenic HCEC-1CT cells (22). The other two are not about cancer. González-Arceo and colleagues in 2023 showed that protein-rich extracts of three algae prevented palmitic-acid-induced triglyceride buildup in AML-12 liver cells, gaditana the most effective (23); that is a different cell model from the 2025 fat-cell paper above. Letsiou and colleagues in 2017 found that a gaditana extract protected human skin cells from hydrogen peroxide stress and raised the antioxidant genes GPX1 and SOD1, alongside changes in other stress-response genes (24). Two of the skin-cell paper's authors work for the TetraSOD manufacturer, and the paper is not indexed in PubMed.

The one human trial, and whose it is

Rao and colleagues in 2020 ran a double-blind, randomized, placebo-controlled trial (neither participants nor staff knew who got the real oil) in 120 healthy adults for twelve weeks at one gram a day (6). The product was AlmegaPL, a polar-lipid-rich oil from a Nannochloropsis alga, with EPA above twenty-five percent of its fatty acids and no DHA. The Omega-3 Index (the share of EPA and DHA in red blood cell membranes) rose from 4.96 to 5.75, and blood EPA rose from 0.82 percent to 1.27 percent.

VLDL cholesterol (the particles that carry fat through the blood) fell twenty-five percent, which drove a drop in total cholesterol against placebo, with no rise in LDL. The paper names only the genus, so I cannot tell you it was gaditana. Two of the four authors work for Qualitas Health, the company behind the oil. The trial supports one narrow statement: an extracted Nannochloropsis oil raised blood EPA in healthy adults over three months.

It does not name gaditana and it did not test the powder, so I treat it as the nearest published neighbor rather than proof of the powder. No human trial exists on gaditana itself (a PubMed search on November 2, 2026 returned no published human trial of Nannochloropsis gaditana supplementation).

A second organism: Tetraselmis chuii and our TetraSOD

This section covers the second organism in TetraSOD Plus Gaditana. TetraSOD is a patented growth preservation process for a freeze-dried biomass of Tetraselmis chuii, a cultivated marine microalga in a different genus, and its claim to fame is superoxide dismutase, an enzyme that disarms superoxide, a reactive form of oxygen. The 25 milligrams in our TetraSOD product is this organism, and the rest of the serving is gaditana. Mantecón and colleagues in 2019 fed rats the freeze-dried alga for 90 days under OECD guideline 408 (the standard repeated-dose toxicity protocol) at up to 2,500 milligrams per kilogram per day and saw no treatment-related deaths or changes in blood, organs or tissue (25). Its lead author works for the TetraSOD manufacturer.

Gil-Cardoso and colleagues in 2022 fed rats a cafeteria diet (a junk-food diet that induces metabolic syndrome) for eight weeks with the alga at 0.17 to 17 milligrams per kilogram per day (26). Liver glutathione peroxidase and glutathione rose and several plasma markers of oxidation and inflammation shifted. It is an animal study, and four of its seven authors work for the TetraSOD manufacturer. The human work comes from one group studying Oceanix, a Lonza product made from this same species, and the papers carry a Lonza conflict of interest.

Sharp and colleagues in 2020 gave people 25 milligrams a day of Oceanix for 14 days (27). After cross-training, the Oceanix group kept squat-jump power and isometric strength better than placebo and had lower creatine kinase (CK, a blood marker of muscle damage). Two more papers followed: Sharp and colleagues in 2021 in Physical Activity and Nutrition writes “Oceanix®, Tetraselmis chuii” (28) and followed 22 people, in whom placebo takers lost isometric rate of force development (how fast you can build force) and salivary IgA (an immune marker) while Oceanix takers did not; the third, in the International Journal of Sports Medicine, names Tetraselmis chuii (Oceanix) and reported better perceived recovery after five weeks of deliberate overreaching (29).

Same species does not mean same preparation: the exercise-recovery papers are on Oceanix, while the soccer trial and the semen pilot are on TetraSOD. Toro and colleagues in 2020 gave 32 amateur soccer players 200 milligrams of TetraSOD a day for thirty days, double-blind and against a placebo group taking 200 milligrams of lactose powder (30). Heart rate fell, and oxygen pulse, VO2max (the top rate at which the body can use oxygen) and hemoglobin all rose. The algae came from the TetraSOD manufacturer. The soccer trial used eight times the 25 milligrams of TetraSOD in our product.

Corral and colleagues in 2023 gave 40 men with idiopathic infertility 25 or 250 milligrams a day of TetraSOD for 90 days (31). At three months, the 250 milligram arm finished with a semen volume of 3.09 milliliters against 2.45 in the 25 milligram arm, a sperm concentration of 17.16 million per milliliter against 11.63, a total sperm number of 52.75 million against 28.17, and progressive motility of 32.85 percent against 26.10.

The paper's percentage increases of 34.93, 86.16, 137.6 and 25.86 percent are that arm's changes versus its own starting values, not the gap between the two arms, and the share of normally shaped sperm did not change. While one can say there is no placebo group in this semen study, and that is true, the participant's sperm were tested at the beginning before the TetraSOD intervention. The paper also lists that as its own first limitation, and it makes the result promising rather than proven: both arms got the active ingredient, so the size of the improvement could be inflated by chance or time. The abstract says double-blind while the methods say single-blind, there were 20 men per arm, PubMed does not index this article, and the funder and four authors are the manufacturer. None of that makes the numbers fake. It makes them a pilot, and a pilot worth repeating at the 250 milligram dose, which is ten times the level of TetraSOD in one serving of our product.

The research in summary

Gaditana's mechanism holds up: a cell that stores oil when starved of nitrogen, an EPA-heavy fat profile without DHA, a pigment set anchored by violaxanthin, and a wall between the powder and the gut. The animal and cell record is substantial and consistent, from diabetic rats to fish to dish studies on liver, fat, skin and cancer cells, all of it laboratory findings rather than treatments. The human record is early, which is the normal state of a good ingredient before the trials catch up.

Which Strain Should You Get?

Side-by-side comparison of Microchloropsis gaditana and Tetraselmis chuii, with each organism's evidence shown against its own preparation.
Same species does not mean same preparation: the exercise-recovery papers are on Oceanix, while the soccer trial and the semen pilot are on TetraSOD.

Two products come out of this alga. LiveMineral Gaditana is Microchloropsis gaditana on its own, one strain, nothing added. TetraSOD Plus Gaditana is the same gaditana with 25 milligrams of TetraSOD per serving, the Tetraselmis chuii ingredient covered above. Both are cultivated in Spain and processed in the United States. Both products are available on this site: LiveMineral Gaditana and TetraSOD Plus Gaditana.

Disclaimer: I am not a health professional of any kind and make no medical claims. I am just a researcher who likes to dig deep on effective methods to keep them from being lost to the dust bin of history. And I like to write about what I learn. So please do your own research. Nothing in this article should be considered medical advice. None of the statements have been evaluated by the FDA. Not intended to diagnose, treat, cure or prevent any disease. If you have a medical condition seek professional help.

References

  1. Lubián LM. Nannochloropsis gaditana spec. nov., una nueva Eustigmatophyceae marina. Lazaroa. 1982;4:287–293. revistas.ucm.es.
  2. Fawley MW, Jameson I, Fawley KP. The phylogeny of the genus Nannochloropsis (Monodopsidaceae, Eustigmatophyceae), with descriptions of N. australis sp. nov. and Microchloropsis gen. nov. Phycologia. 2015;54(5):545–552. doi:10.2216/15-60.1.
  3. Rodolfi L, Chini Zittelli G, Bassi N, Padovani G, Biondi N, Bonini G, Tredici MR. Microalgae for oil: strain selection, induction of lipid synthesis and outdoor mass cultivation in a low-cost photobioreactor. Biotechnol Bioeng. 2009;102(1):100–112. doi:10.1002/bit.22033. PMID 18683258.
  4. Simionato D, Block MA, La Rocca N, Jouhet J, Maréchal E, Finazzi G, Morosinotto T. The response of Nannochloropsis gaditana to nitrogen starvation includes de novo biosynthesis of triacylglycerols, a decrease of chloroplast galactolipids, and reorganization of the photosynthetic apparatus. Eukaryot Cell. 2013;12(5):665–676. doi:10.1128/ec.00363-12. PMID 23457191.
  5. Navalho S, Ferrer-Ledo N, Barbosa MJ, Varela J. Nannochloropsis Lipids and Polyunsaturated Fatty Acids: Potential Applications and Strain Improvement. Mar Drugs. 2025;23(3):128. doi:10.3390/md23030128. PMID 40137314.
  6. Rao A, Briskey D, Nalley JO, Ganuza E. Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga Nannochloropsis Decreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized, Placebo-Controlled, Three-Month Supplementation Study. Nutrients. 2020;12(6):1869. doi:10.3390/nu12061869. PMID 32585854.
  7. Burdge GC. Alpha-linolenic acid interconversion is sufficient as a source of longer chain omega-3 polyunsaturated fatty acids in humans: An opinion. Lipids. 2022;57(6):267–287. doi:10.1002/lipd.12355. PMID 35908848.
  8. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22. doi:10.1056/NEJMoa1812792. PMID 30415628.
  9. Lima S, Schulze PSC, Schüler LM, Rautenberger R, Morales-Sánchez D, Santos TF, Pereira H, Varela JCS, Scargiali F, Wijffels RH, Kiron V. Flashing light emitting diodes (LEDs) induce proteins, polyunsaturated fatty acids and pigments in three microalgae. J Biotechnol. 2021;325:15–24. doi:10.1016/j.jbiotec.2020.11.019. PMID 33245925.
  10. Culetu A, Kreische M, Schweikert T, Henze A, Sagu ST. Unveiling the bioactive potential of microalgae: Integrative analysis of nutritional composition and peptidomic signatures. Food Chem. 2026;506:148081. doi:10.1016/j.foodchem.2026.148081. PMID 41616454.
  11. Nacer W, Baba Ahmed FZ, Merzouk H, Benyagoub O, Bouanane S. Evaluation of the anti-inflammatory and antioxidant effects of the microalgae Nannochloropsis gaditana in streptozotocin-induced diabetic rats. J Diabetes Metab Disord. 2020;19(2):1483–1490. doi:10.1007/s40200-020-00681-3. PMID 33553035.
  12. Scholz MJ, Weiss TL, Jinkerson RE, Jing J, Roth R, Goodenough U, Posewitz MC, Gerken HG. Ultrastructure and composition of the Nannochloropsis gaditana cell wall. Eukaryot Cell. 2014;13(11):1450–1464. doi:10.1128/ec.00183-14. PMID 25239976.
  13. Cavonius LR, Albers E, Undeland I. In vitro bioaccessibility of proteins and lipids of pH-shift processed Nannochloropsis oculata microalga. Food Funct. 2016;7(4):2016–2024. doi:10.1039/c5fo01144b. PMID 27045666.
  14. Wild KJ, Steingaß H, Rodehutscord M. Variability in nutrient composition and in vitro crude protein digestibility of 16 microalgae products. J Anim Physiol Anim Nutr. 2018;102(5):1306–1319. doi:10.1111/jpn.12953. PMID 29981178.
  15. Ferreira M, Coutinho P, Seixas P, Fábregas J, Otero A. Enriching rotifers with "premium" microalgae. Nannochloropsis gaditana. Mar Biotechnol (NY). 2009;11(5):585–595. doi:10.1007/s10126-008-9174-x. PMID 19153793.
  16. Díaz N, Muñoz S, Medina A, Riquelme C, Lozano-Muñoz I. Microchloropsis gaditana as a Natural Antimicrobial with a One Health Approach to Food Safety in Farmed Salmon. Life (Basel). 2025;15(3):455. doi:10.3390/life15030455. PMID 40141798.
  17. Mavrommatis A, Correddu F, Kyriakaki P, Satolias FF, Nudda A, Tsiplakou E. Effects of dietary Schizochytrium spp. alone or combined with Nannochloropsis gaditana on milk fatty acid profile and oxidative status in lactating ewes. J Anim Sci. 2026;104:skag256. doi:10.1093/jas/skag256. PMID 42606591.
  18. González-Arceo M, Aguirre L, Ibarruri J, Cebrián M, Martín MA, Portillo MP, Gómez-Zorita S. Effects of Chlorella vulgaris, Microchloropsis Gaditana and Gracilaria vermiculophylla algae extracts on maturing and mature 3T3-L1 adipocytes. Sci Rep. 2025;15(1):32891. doi:10.1038/s41598-025-10202-y. PMID 40998879.
  19. Martínez R, García-Beltrán A, Kapravelou G, et al. In Vivo Nutritional Assessment of the Microalga Nannochloropsis gaditana and Evaluation of the Antioxidant and Antiproliferative Capacity of Its Functional Extracts. Mar Drugs. 2022;20(5):318. doi:10.3390/md20050318. PMID 35621969.
  20. Carrasco-Reinado R, Escobar-Niño A, Fajardo C, et al. Development of New Antiproliferative Compound against Human Tumor Cells from the Marine Microalgae Nannochloropsis gaditana by Applied Proteomics. Int J Mol Sci. 2021;22(1):96. doi:10.3390/ijms22010096. PMID 33374179.
  21. Ávila-Román J, Talero E, de los Reyes C, Zubía E, Motilva V, García-Mauriño S. Cytotoxic Activity of Microalgal-derived Oxylipins against Human Cancer Cell Lines and their Impact on ATP Levels. Nat Prod Commun. 2016;11(12):1871–1875. doi:10.1177/1934578X1601101225. PMID 30508355.
  22. Castejón N, Marko D. Fatty Acid Composition and Cytotoxic Activity of Lipid Extracts from Nannochloropsis gaditana Produced by Green Technologies. Molecules. 2022;27(12):3710. doi:10.3390/molecules27123710. PMID 35744834.
  23. González-Arceo M, Trepiana J, Aguirre L, et al. Anti-Steatotic Effects of Chlorella vulgaris, Nannochloropsis gaditana and Gracilaria vermiculophylla Algae Extracts in AML-12 Hepatocytes. Nutrients. 2023;15(8):1960. doi:10.3390/nu15081960. PMID 37111177.
  24. Letsiou S, Kalliampakou K, Gardikis K, et al. Skin Protective Effects of Nannochloropsis gaditana Extract on H2O2-Stressed Human Dermal Fibroblasts. Front Mar Sci. 2017;4:221. doi:10.3389/fmars.2017.00221. (Not indexed in PubMed.)
  25. Mantecón L, Moyano R, Cameán AM, Jos Á. Safety assessment of a lyophilized biomass of Tetraselmis chuii (TetraSOD®) in a 90-day feeding study. Food Chem Toxicol. 2019;133:110810. doi:10.1016/j.fct.2019.110810. PMID 31505236.
  26. Gil-Cardoso K, Del Bas JM, Caimari A, Lama C, Torres S, Mantecón L, Infante C. TetraSOD®, a Unique Marine Microalgae Ingredient, Promotes an Antioxidant and Anti-Inflammatory Status in a Metabolic Syndrome-Induced Model in Rats. Nutrients. 2022;14(19):4028. doi:10.3390/nu14194028. PMID 36235679.
  27. Sharp M, Sahin K, Stefan M, Orhan C, Gheith R, Reber D, Sahin N, Tuzcu M, Lowery R, Durkee S, Wilson J. Phytoplankton Supplementation Lowers Muscle Damage and Sustains Performance across Repeated Exercise Bouts in Humans and Improves Antioxidant Capacity in a Mechanistic Animal. Nutrients. 2020;12(7):1990. doi:10.3390/nu12071990. PMID 32635494. Erratum: Nutrients. 2022;14(3):408. doi:10.3390/nu14030408.
  28. Sharp M, Wilson J, Stefan M, Gheith R, Lowery R, Ottinger C, Reber D, Orhan C, Sahin N, Tuzcu M, Durkee S, Saiyed Z, Sahin K. Marine Phytoplankton Improves Recovery and Sustains Immune Function in Humans and Lowers Proinflammatory Immunoregulatory Cytokines in a Rat Model. Phys Act Nutr. 2021;25(1):42–55. doi:10.20463/pan.2021.0007. PMID 33887828.
  29. Sharp MH, Sahin K, Stefan MW, Gheith RH, Reber DD, Ottinger CR, Orhan C, Tuzcu M, Sahin N, Lowery RP, Durkee S, Wilson JM. Marine Phytoplankton Improves Exercise Recovery in Humans and Activates Repair Mechanisms in Rats. Int J Sports Med. 2021;42(12):1070–1082. doi:10.1055/a-1320-1061. PMID 33352600.
  30. Toro V, Siquier-Coll J, Bartolomé I, Robles-Gil MC, Rodrigo J, Maynar-Mariño M. Effects of Tetraselmis chuii Microalgae Supplementation on Ergospirometric, Haematological and Biochemical Parameters in Amateur Soccer Players. Int J Environ Res Public Health. 2020;17(18):6885. doi:10.3390/ijerph17186885. PMID 32967151.
  31. Corral JM, Jodar M, Matheu R, González E, Castaño E, Unamunzaga C, Mantecón L, Infante C. Improvement of Semen Quality in Idiopathic Infertile Men by Dietary Supplementation with TetraSOD®: A Pilot Clinical Trial. Biomed J Sci Tech Res. 2023;50(4):41971–41975. doi:10.26717/BJSTR.2023.50.007999. (Not indexed in PubMed.)